Skip to main content
. 2016 Dec;101(12):1573–1580. doi: 10.3324/haematol.2016.144576

Figure 2.

Figure 2.

Overall survival (OS) and progression-free survival (PFS). Kaplan-Meier curves of PFS in (A) all patients and (B) patients with or without del(17p)/TP53 mutation and OS in (C) all patients and (D) patients with or without del(17p)/TP53 mutation.